TropQI has been a part of The Malaria Drug Accelerator (MalDA) since 2018. This consortium consists of 17 research laboratories funded by the Bill and Melinda Gates foundation to advance the development of novel anti-malarial drugs. This review describes the consortiums mission and their accomplishments to date.